Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Want to cut your energy bills? Here’s how five experts are doing it 
Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/rhvbfw/metered_dose) has announced the addition of the "Metered Dose Inhalers to 2022" report to their offering.
This report examines the current and future metered dose inhalers market and the key topics all market participants should be aware of. Recent improvements in the control of the inspiry event have reduced the need for add-on devices designed to help regulate patient administration. Growth in upper airway therapeutics will help to push MDI unit demand to high single digits between now and the end of the decade.
Questions Answered:
- What inhalable drugs are supplied in MDIs, how are they marketed, what are the device specifics, and who markets them?
- What inhalable MDI products are in late stage development, who are the developers, and what indications are they targeting?
- What are the major factors driving metered dose inhaled drug/device demand?
- What is the size of the market today, who are the market share leaders, and what will the market share be in 2022?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
- What are the essential design factors, material selection issues, technologies and market development issues MDI products?
- What are the significant economic, technology, and regulatory factors affecting the market for MDIs?
Report Structure:
1. Executive Summary
2. Inhaled Drug Delivery Market Dynamics
3. Devices and Formulations
4. MDI Technology Factors
5. MDI Performance Factors
6. MDI Product Assessments and Analysis
7. Therapeutic Market Analysis, Market Data and Forecasts
8. Market Factors
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/rhvbfw/metered_dose
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers, Respiratory Devices
